Biogened Dividend

Dividend criteriumcontroles 2/6

Biogened is a dividend paying company with a current yield of 2.14% that is well covered by earnings. Next payment date is on 18th November, 2024 with an ex-dividend date of 12th September, 2024.

Belangrijke informatie

2.1%

Dividendrendement

n/a

Terugkoop Rendement

Totaal aandeelhoudersrendementn/a
Toekomstig dividendrendementn/a
Dividendgroein/a
Volgende betaaldatum dividend18 Nov 24
Ex-dividenddatum12 Sep 24
Dividend per aandeelzł0.500
Uitbetalingsratio23%

Recente dividendupdates

Recent updates

A Piece Of The Puzzle Missing From Biogened S.A.'s (WSE:BGD) 25% Share Price Climb

Aug 28
A Piece Of The Puzzle Missing From Biogened S.A.'s (WSE:BGD) 25% Share Price Climb

Impressive Earnings May Not Tell The Whole Story For Biogened (WSE:BGD)

Aug 22
Impressive Earnings May Not Tell The Whole Story For Biogened (WSE:BGD)

Investors Give Biogened S.A. (WSE:BGD) Shares A 37% Hiding

May 23
Investors Give Biogened S.A. (WSE:BGD) Shares A 37% Hiding

Here's Why Biogened (WSE:BGD) Has A Meaningful Debt Burden

May 09
Here's Why Biogened (WSE:BGD) Has A Meaningful Debt Burden

Biogened's (WSE:BGD) Promising Earnings May Rest On Soft Foundations

Feb 21
Biogened's (WSE:BGD) Promising Earnings May Rest On Soft Foundations

Is Biogened (WSE:BGD) A Risky Investment?

Feb 01
Is Biogened (WSE:BGD) A Risky Investment?

Biogened S.A. (WSE:BGD) Looks Just Right With A 37% Price Jump

Feb 01
Biogened S.A. (WSE:BGD) Looks Just Right With A 37% Price Jump

We Think Biogened (WSE:BGD) Can Stay On Top Of Its Debt

Jun 30
We Think Biogened (WSE:BGD) Can Stay On Top Of Its Debt

Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly

Oct 08
Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly

Is Biogened (WSE:BGD) A Risky Investment?

Jun 29
Is Biogened (WSE:BGD) A Risky Investment?

Does Biogened (WSE:BGD) Have A Healthy Balance Sheet?

Mar 25
Does Biogened (WSE:BGD) Have A Healthy Balance Sheet?

These 4 Measures Indicate That Biogened (WSE:BGD) Is Using Debt Reasonably Well

Dec 09
These 4 Measures Indicate That Biogened (WSE:BGD) Is Using Debt Reasonably Well

Biogened (WSE:BGD) Has A Somewhat Strained Balance Sheet

Jul 29
Biogened (WSE:BGD) Has A Somewhat Strained Balance Sheet

Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly

Apr 30
Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly

Is Biogened (WSE:BGD) A Risky Investment?

Jan 24
Is Biogened (WSE:BGD) A Risky Investment?

Stabiliteit en groei van betalingen

Dividenden ophalen

Stabiel dividend: Whilst dividend payments have been stable, BGD has been paying a dividend for less than 10 years.

Groeiend dividend: BGD's dividend payments have increased, but the company has only paid a dividend for 3 years.


Dividendrendement versus markt

Biogened Dividendrendement versus markt
Hoe verhoudt BGD dividendrendement zich tot de markt?
SegmentDividendrendement
Bedrijf (BGD)2.1%
Markt onderkant 25% (PL)2.8%
Markt Top 25% (PL)8.0%
Gemiddelde industrie (Pharmaceuticals)2.4%
Analist prognose (BGD) (tot 3 jaar)n/a

Opmerkelijk dividend: BGD's dividend (2.14%) isn’t notable compared to the bottom 25% of dividend payers in the Polish market (2.82%).

Hoog dividend: BGD's dividend (2.14%) is low compared to the top 25% of dividend payers in the Polish market (7.96%).


Winstuitkering aan aandeelhouders

Verdiendekking: With its low payout ratio (22.9%), BGD's dividend payments are well covered by earnings.


Contante uitbetaling aan aandeelhouders

Kasstroomdekking: With its reasonably low cash payout ratio (30.1%), BGD's dividend payments are well covered by cash flows.


Ontdek bedrijven met een sterk dividend